Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.39 USD
-0.22 (-13.66%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $1.42 +0.03 (2.16%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Earnings News For CHRS
-
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
-
Coherus BioSciences: Q1 Earnings Snapshot
-
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
-
Coherus BioSciences: Q4 Earnings Snapshot
-
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
-
Coherus BioSciences: Q3 Earnings Snapshot
-
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
-
Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates
-
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
-
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
-
Coherus BioSciences: Q1 Earnings Snapshot
-
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
-
Coherus BioSciences (CHRS) Reports Q4 Loss, Misses Revenue Estimates
-
Coherus BioSciences: Q4 Earnings Snapshot
-
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
-
Coherus BioSciences (CHRS) Reports Q3 Loss, Lags Revenue Estimates
-
Coherus BioSciences: Q3 Earnings Snapshot
-
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
-
Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates
-
Coherus BioSciences: Q2 Earnings Snapshot
-
Coherus BioSciences Reports Second Quarter 2022 Results and Provides Business Update
-
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
-
Coherus BioSciences (CHRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Coherus BioSciences (CHRS) Reports Q4 Loss, Misses Revenue Estimates
-
Coherus BioSciences (CHRS) Reports Q3 Loss, Misses Revenue Estimates